Psychedelic Stocks Archives - Page 59 of 61

MondayJan 24, 2022 10:49 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) to Launch Specialized Psychedelic Program in Canada

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) announced that it would be launching a special access psychedelic-assisted psychotherapy program, called the Special Access Support and Supply Program. The program will be available to patients who require alternative treatment modalities in Canada. The country recently added psilocybin and MDMA to its Special Access Program. Mydecine’s objective is to change the way in which mental health conditions and addiction disorders are treated. The company will provide support services through the program, which will play an important role in fulfilling the company’s mission statement. This is in addition to offering specialized psychedelic…

FridayJan 21, 2022 10:35 am

Ancient Latin American Empire Could Have Thrived Thanks to Psychedelic-Infused Beer

A new study has found that the leaders of Wari may have laced their beer with hallucinogens to keep their political control for centuries. The drugs are said to have been extracted from plant seeds. The Wari are a South American civilization that ruled the highlands of what is now known as Peru, before the Incas. The culture occupied the highlands between 600 AD and 1000 AD. Archaeological excavations that were conducted between 2013 and 2017 at the Quilcapampa site in the south of Peru have discovered that the tribe used seeds derived from the vilca tree then combined the…

ThursdayJan 20, 2022 10:03 am

Study Finds That Sleep Deprivation Increases Serotonin 2AReceptor Levels in Brain

A new study conducted by researchers at the University of Arizona Health Sciences has found that sleep deprivation can cause a significant increase in serotonin 2A levels in a matter of hours in animal models.Serotonin 2A, or the 5-HT2A receptor, plays a crucial role in cognition, perception and psychosis. The receptor is extensively distributed in the brain and is responsible for the psychedelic effect of substances such as LSD and psilocybin. Abnormal function of 5-HT2A receptors has been linked to psychiatric disorders, including schizophrenia, which explains why antipsychotic medications prescribed for the treatment of schizophrenia have been designed to target…

WednesdayJan 19, 2022 2:21 pm

Canada Achieves New Psychedelic Milestone After Holding First Psilocybin Therapy Group Session

Canada held its first legal psilocybin therapy group session recently. Psilocybin is an active hallucinogenic compound found in magic mushrooms. Various studies conducted by major research institutions have found that psilocybin possesses therapeutic benefits. For instance, studies by Johns Hopkins University, New York University and the University of California Los Angeles have discovered that psilocybin can be used to effectively decrease end-of-life distress in patients with terminal conditions. The session, which was hosted in Vancouver, British Columbia, was facilitated by My Community Journeys, a not-for-profit health-care organization. The therapy session included nine end-of-life patients who had received legal exemptions from…

TuesdayJan 18, 2022 3:45 pm

Washington State Bill Seeks to Legalize Medical Use of Psilocybin

Last week, two legislators from Washington State introduced a proposal that would legalize psilocybin services in the state. The bill, dubbed SB5660, would permit individuals aged 21 and above to consume products that contain psilocin and psilocybin under the supervision of a state-licensed and trained psilocybin service administrator. Psilocin and psilocybin are the two primary active ingredients found in magic mushrooms. Individuals with certain medical conditions that render them unable to go to a licensed service center would be allowed to meet with facilitators remotely and be administered these products at home. Other individuals who don’t meet this criterion would…

FridayJan 14, 2022 11:06 am

Health Canada Permits Physicians to Prescribe Psychedelic Drugs for Mental Illnesses

The Special Access Program by Health Canada allows patients with life-threatening mental health conditions whose previous treatments have been ineffective to begin using MDMA and psilocybin mushrooms as part of their treatment. Before physicians were allowed to prescribe these medicines, the drugs could only be used after an exemption was granted for individual palliative cases by Health Canada. David Harder states that this move, which allows physicians to prescribe psychedelics in their practices, is a huge shift with regard to psychedelic legalization in Canada. Harder, who operates the ATMA Calgary Urban Journey Center, added that physicians would still be required…

ThursdayJan 13, 2022 1:56 pm

Veterans with PTSD to Receive Service Dogs Under PAWS Act

Service dogs in the United States are usually given to former service members of the military as a form of support after the soldiers have served the country. Individuals who qualify to receive the free service dogs have to meet various qualifications, which include having emotional or physical disabilities. K9s for Warriors, advocates and Canine Companions have been calling for the Veterans Affairs Department to provide support to veterans with PTSD by giving them service dogs. However, until recently, individuals with mental trauma weren’t eligible to receive these support dogs. Canine Companions offers service dogs to children, adults and veterans…

WednesdayJan 12, 2022 12:37 pm

Four Hidden Psychedelic Truths in ‘The Matrix Resurrections’

“The Matrix” was first released in 1999, and since then, three more sequels have been released: “The Matrix Reloaded,” “The Matrix Revolutions” and “The Matrix Resurrections,” each one more thrilling and captivating than the last. One thing that may catch your eye with this latest release is how trippy the film is, from guided spiritual journeys to flashbacks that bend reality. Today, we look at ways in which “The Matrix Resurrections” is more psychedelic than the first film in the sequence. Slowing time In the first movie, Neo got out of trouble by slowing down the time around him. In…

TuesdayJan 11, 2022 1:03 pm

Psychedelics May Shed Light on How Perception Occurs

Anil Seth, a neuroscientist at the University of Sussex, has been studying how the brain helps individuals perceive the world around them. The researcher is interested in what psychedelics like LSD can reveal to us about how the brain develops different perceptions. Seth has tried LSD and ayahuasca, both experiences leaving him with a strengthened conviction that these substances possess the potential to teach us about the workings of the brain, which produces perceptions. He isn’t the only advocate, as more neuroscientists, armed with computational models of the brain, EEG recordings, fMRI scans and volunteer reports, try to understand how…

MondayJan 10, 2022 1:36 pm

University of Texas-Austin Launches Center for Psychedelic Research and Therapy

The University of Texas at Austin recently established a Center for Psychedelic Research and Therapy. This comes months after the state’s governor signed a proposal that instructs the state to conduct research on the benefits and risks of ketamine, MDMA and psilocybin for veterans. Prof. Charles B. Nemeroff, the center’s co-lead, stated that the center would bring more scientific expertise and rigor to study psychedelic therapy. Nemeroff is also the chair of the Department of Behavioral Sciences and Psychiatry at the Dell Medical School. The center, which is the first of its kind in the state, will allow researchers to…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks